Lp-PLA2 Activity Test (Vascular Inflammation) Biomarker Testing
It measures Lp-PLA2 enzyme activity linked to plaque inflammation and heart risk, with convenient ordering and Quest lab access through Vitals Vault.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
Lp-PLA2 Activity is a blood test that looks at an enzyme involved in inflammation inside artery walls. It is often discussed in the context of “plaque activity,” meaning whether cholesterol plaque may be more inflamed and prone to causing problems.
This test does not diagnose a heart attack, stroke, or blocked artery by itself. Instead, it can add detail to your overall cardiovascular risk picture, especially when you are trying to understand risk beyond standard cholesterol numbers.
Because heart risk is usually about patterns, Lp-PLA2 Activity is most useful when you interpret it alongside markers like LDL-C, ApoB, lipoprotein(a), triglycerides, blood pressure, and blood sugar trends.
Do I need a Lp-PLA2 Activity test?
You might consider Lp-PLA2 Activity testing if you and your clinician are trying to refine your cardiovascular risk—particularly when your standard lipid panel does not fully explain your family history, imaging findings, or overall risk profile.
This test can be helpful if you have risk factors such as high LDL-C or ApoB, metabolic syndrome, type 2 diabetes, smoking history, chronic kidney disease, or a strong family history of early heart disease. It is also sometimes used when you have already made lifestyle changes or started lipid-lowering therapy and you want another data point to track whether vascular inflammation risk appears to be improving.
You do not usually need this test for routine screening if your risk is clearly low and your standard markers are consistently favorable. On the other hand, if your risk is clearly high based on established disease or major risk factors, management decisions often rely more on proven targets (like ApoB/LDL-C and blood pressure) than on any single inflammation-related marker.
Your result is best used to support clinician-directed care and shared decision-making, not to self-diagnose cardiovascular disease.
Lp-PLA2 Activity is measured in a CLIA-certified laboratory; results should be interpreted in clinical context and are not a standalone diagnosis of cardiovascular disease.
Lab testing
Order Lp-PLA2 Activity through Vitals Vault and complete your draw at Quest.
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this test with Vitals Vault
Vitals Vault lets you order Lp-PLA2 Activity testing without a separate doctor’s visit, and then complete your blood draw through the Quest network. This is useful when you want a clear, documented baseline or you are planning a structured retest after lifestyle or medication changes.
After your results are in, you can use PocketMD to ask practical questions like how to interpret your number, which companion labs add the most clarity, and what retest timing makes sense for your situation. If your result suggests higher vascular inflammation risk, PocketMD can also help you prepare focused questions for your clinician.
If you are building a broader cardiovascular picture, you can pair this test with related markers (such as ApoB, hs-CRP, lipoprotein(a), and A1c) so you are not making decisions from a single data point.
- Order online and draw at participating Quest locations
- Results you can discuss with your clinician, with PocketMD support
- Easy retesting to track trends over time
Key benefits of Lp-PLA2 Activity testing
- Adds a plaque-inflammation–related signal that can complement standard cholesterol numbers.
- Helps refine risk discussions when family history or other factors suggest risk beyond a basic lipid panel.
- Can support monitoring of cardiovascular risk patterns over time, especially when you are making treatment changes.
- May help explain why risk still looks elevated even when LDL-C appears “okay,” prompting a deeper look at ApoB, Lp(a), and insulin resistance.
- Encourages a more complete workup by pairing with companion markers like hs-CRP, ApoB, and A1c rather than relying on one lab.
- Provides a concrete baseline you can retest against after lifestyle changes or medication adjustments.
- Fits into a convenient order-and-interpret workflow through Vitals Vault and PocketMD.
What is Lp-PLA2 Activity?
Lp-PLA2 stands for lipoprotein-associated phospholipase A2. It is an enzyme carried in the bloodstream, largely attached to LDL particles. The “activity” test measures how active that enzyme is, which is one way to estimate inflammatory processes related to atherosclerotic plaque.
In simplified terms, higher Lp-PLA2 activity can be a sign that there is more inflammation happening in and around artery-wall plaque. That matters because plaque that is more inflamed is more likely to be unstable, which is one pathway toward cardiovascular events.
Lp-PLA2 is not the same as general inflammation markers like hs-CRP. It is considered more vascular-specific, although it still needs to be interpreted alongside your overall risk factors and other labs.
Activity vs. mass: why the wording matters
Some labs report Lp-PLA2 “mass” (how much enzyme is present), while others report “activity” (how much enzyme function is detected). These are related but not identical. If you are tracking trends, try to use the same type of test each time and compare results to the reference range provided by the lab that ran your sample.
How it fits into cardiovascular risk assessment
Most cardiovascular decisions still hinge on well-validated targets such as ApoB/LDL-C, blood pressure, smoking status, diabetes control, and overall risk scoring. Lp-PLA2 Activity can add nuance when you are in a gray zone, when imaging suggests plaque, or when you want to understand whether risk may be driven by more than cholesterol quantity alone.
What do my Lp-PLA2 Activity results mean?
Low Lp-PLA2 Activity
A low result generally suggests less Lp-PLA2-related vascular inflammatory activity at the time of testing. In many cases, this is reassuring, especially if your ApoB/LDL-C, blood pressure, and blood sugar markers are also in a favorable range. Very low values are not usually treated as a problem on their own, but your clinician may still focus on overall risk if you have known plaque or major risk factors.
Optimal (in-range) Lp-PLA2 Activity
An in-range result suggests your Lp-PLA2 activity is not elevated compared with the lab’s reference population. This can support a lower plaque-inflammation signal, but it does not rule out atherosclerosis or future risk. If your other markers are mixed (for example, high ApoB or high Lp(a)), your clinician may still recommend aggressive risk reduction even with an “optimal” Lp-PLA2 Activity.
High Lp-PLA2 Activity
A high result suggests increased Lp-PLA2-related activity, which can be consistent with higher vascular inflammation and potentially higher cardiovascular risk. This is most meaningful when it aligns with other risk signals such as elevated ApoB/LDL-C, high triglycerides, insulin resistance, smoking, or evidence of plaque on imaging. A high value is usually a prompt to review the full risk picture and consider whether additional testing, treatment optimization, or closer follow-up is appropriate.
Factors that influence Lp-PLA2 Activity
Because Lp-PLA2 is often carried on LDL particles, higher LDL-C or ApoB can be associated with higher Lp-PLA2 activity. Smoking, uncontrolled diabetes, and chronic inflammatory states can also push risk upward, while effective lipid-lowering therapy and risk-factor control may lower the signal over time. Lab-to-lab methods and reference ranges can differ, so trend your results using the same assay when possible. Timing matters too: a single test is a snapshot, and retesting after a stable period (often several weeks to a few months after a change) can be more informative than frequent short-interval checks.
What’s included
Frequently Asked Questions
What is a normal Lp-PLA2 Activity level?
“Normal” depends on the lab method and the reference range printed on your report. Use the range provided with your result, and if you are tracking changes over time, try to use the same lab and the same test type (activity vs. mass) for better apples-to-apples comparisons.
Do I need to fast for an Lp-PLA2 Activity test?
Fasting is not always required for Lp-PLA2 Activity itself, but your clinician may recommend fasting if you are drawing other labs at the same time, such as triglycerides, insulin, or a comprehensive metabolic panel. If you are bundling tests, follow the fasting instructions for the strictest test in your order.
Is Lp-PLA2 the same as hs-CRP?
No. hs-CRP is a general marker of inflammation that can rise with infections, injuries, and many inflammatory conditions. Lp-PLA2 Activity is more tied to processes associated with atherosclerotic plaque and LDL particles, so it can add a different angle to cardiovascular risk assessment.
What does a high Lp-PLA2 Activity mean if my LDL is normal?
It can mean there is a vascular inflammation signal that is not captured by LDL-C alone. In that situation, it is common to look at ApoB (particle number), lipoprotein(a), triglycerides, blood sugar markers (A1c), blood pressure, and lifestyle factors like smoking. Your clinician may also consider imaging or additional labs to clarify risk.
How often should I retest Lp-PLA2 Activity?
Retesting is most useful after something meaningful changes, such as starting or adjusting lipid-lowering therapy, stopping smoking, or making sustained nutrition and exercise changes. Many people retest in the range of 8–12 weeks after a stable change, but the right interval depends on your baseline risk and your clinician’s plan.
Can medications affect Lp-PLA2 Activity?
Yes. Because Lp-PLA2 is linked to LDL particles and vascular risk pathways, therapies that lower LDL/ApoB and improve overall cardiometabolic health may reduce Lp-PLA2 Activity over time. Do not change medications based on this test alone; use it as one piece of a broader risk discussion.
Does Lp-PLA2 Activity diagnose blocked arteries or heart disease?
No. It is a risk-related biomarker, not a diagnostic test for a blockage. If you have symptoms like chest pain, shortness of breath, or neurologic symptoms, you need urgent medical evaluation rather than relying on any lab marker.